In this episode of StockCharts TV's The MEM Edge, Mary Ellen reviews the rotation taking place in the markets following news of a possible vaccine. She also shares top candidates in Biotech stocks as major innovations take place there. In addition, short squeeze plays are uncovered as investors were caught short by COVID-19 treatment news.
This video was originally broadcast on November 13th, 2020. Click on the above image to watch on our dedicated MEM Edge page on StockCharts TV, or click this link to watch on YouTube.
New episodes of The MEM Edge air Fridays at 6:30pm PT on StockCharts TV. You can view all previously recorded episodes at this link. You can also receive a 4-week free trial of her MEM Edge Report by clicking the image below.
About the author:Mary Ellen McGonagle is a professional investing consultant and the president of MEM Investment Research. After eight years of working on Wall Street, Ms. McGonagle left to become a skilled stock analyst, working with William O’Neill in identifying healthy stocks with potential to take off. She has worked with clients that span the globe, including big names like Fidelity Asset Management, Morgan Stanley, Merrill Lynch and Oppenheimer.